Abstract 【Objective】 To investigate the prognostic factors of extracorporeal membrane oxygenation (ECMO) in elderly patients with cardiogenic shock (CGS). 【Methods】 A total of 124 elderly patients with CGS treated in Hancheng people's Hospital and Yanliang Hospital of Xi'an Honghui hospital from January 2018 to February 2021 were treated with ECMO. The prognosis of patients 90 days after ECMO treatment was recorded and divided into survival group and death group. The influencing factors of ECMO treatment prognosis, the effects of SOFA score, blood lactic acid and cTnT on the prognosis of elderly CGS patients were analyzed, and the value of SOFA score, blood lactic acid and cTnT alone and in combination in predicting the prognosis was evaluated. 【Results】 The 90 day survival rate of 124 elderly patients with CGS after ECMO treatment was 75.81%, and the mortality was 24.19%. Univariate analysis showed that the age of death group>75 years old, the time from ICU to ECMO≥5 hours, acute renal injury, SOFA score, blood lactic acid and cTnT before ECMO treatment were higher than those in survival group, and LVEF before ECMO treatment was lower than those in survival group (P<0.05). Multivariate analysis showed that age, time from ICU to ECMO, acute renal injury, LVEF, SOFA score, blood lactic acid and cTnT before ECMO treatment were the influencing factors of the prognosis of elderly patients with CGS after ECMO treatment (P<0.05). Before ECMO treatment, the area under the curve (AUC) of SOFA score, blood lactic acid and cTnT to predict the prognosis of elderly CGS patients after ECMO treatment was > 0.7. The AUC predicted by the combination of various indexes was the largest, which was 0.947. The best prediction sensitivity and specificity were 86.67% and 90.43% respectively. 【Conclusion】 ECMO is effective in the treatment of elderly patients with CGS. The combination of SOFA score, blood lactic acid and cTnT before treatment is of high value in predicting the prognosis of patients.
LIU Jian-hong,YAN Hong-fang. Prognostic Factors of Extracorporeal Membrane Oxygenation in Elderly Patients with Cardiogenic Shock[J]. JOURNAL OF CLINICAL RESEARCH, 2022, 39(5): 725-728.
[1] BELLUMKONDA L,GUL B,MASRI S C.Evolvingconcepts in diagnosis and management of cardiogenic shock[J].Am J Cardiol,2018,122(6):1104-1110.
[2] 屠国伟,罗哲,王春生,等.复旦大学附属中山医院心源性休克VA-ECMO治疗规范(V1.2019)[J].中国临床医学,2019,26(4):667-672.
[3] 阿依努尔,贾旭东,陈慧.慢性肺源性心脏病合并心源性休克患者预后风险模型的建立及研究[J].临床和实验医学杂志,2020,19(18):1940-1943.
[4] KIM K S,SUH G J,KIM K, et al. Quick sepsis-related organ failure assessment score is not sensitive enough to predict 28-day mortality in emergency department patients with sepsis: a retrospective review[J].Clin Exp Emerg Med,2019,6(1):77-83.
[5] LEVY B, BASTIEN O, KARIM B, et al. Experts' recommendations for the management of adult patients with cardiogenic shock[J].Ann Intensive Care,2015,5(1):52.
[6] 刘炳炜,徐燕平,席绍松,等.SOFA评分联合PCT检测对脓毒症患者病情及其预后的临床评估价值[J].中华全科医学,2021,19(3):391-393.
[7] 卢安东,郭剑,苗莉霞,等.心脏术后体外膜肺氧合支持临床应用探讨[J].中国体外循环杂志,2017,15(2):100-104.
[8] 石光,刘建华,祖晓麟,等.体外膜肺氧合治疗老年心原性休克患者预后和影响因素分析[J].中华老年医学杂志,2019,38(5):529-532.
[9] BIANCARI F,PERROTTI A,DALÉN M,et al.Meta-Analysis of the Outcome After Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation in Adult Patients[J].J Cardiothorac Vasc Anesth,2018,32(3):1175-1182.
[10] 魏小红,刘文娴,陈立颖,等.急性心肌梗死合并心源性休克患者急诊冠脉介入术后院内死亡危险因素分析[J].中华急诊医学杂志,2019,28(5):619-624.
[11] AHMED H H, DE BELS D, ATTOU R, et al. Elevated lactic acid during ketoacidosis: pathophysiology and management[J].J Transl Int Med,2019,7(3):115-117.
[12] 刘德林,王玉光,王敏娜,等.血乳酸测定评估ECMO治疗的心源性休克患者预后价值[J].中华胸心血管外科杂志,2019,35(10):617-622.
[13] 季苏琼,李悦,徐丽,等.肌钙蛋白对于免疫介导的坏死性肌病合并心脏损伤患者的意义[J].神经损伤与功能重建,2020,15(4):201-203.
[14] 杨亚南,邵换璋,史源,等.肝素结合蛋白联合SOFA评分对脓毒性休克的预测价值[J].中华危重病急救医学,2019,31(3):336-340.
[1]
. [J]. JOURNAL OF CLINICAL RESEARCH, 2022, 39(5): 793-795.
2022, Vol. 39 
